• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vicore Pharma Holding

12.22 SEK-4.23 %13/7 17:29
Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-4.23 %
+15.50 %
+22.57 %
+0.66 %
+8.14 %
+60.79 %
-17.48 %
-39.33 %
+141.98 %

Vicore Pharma Holding operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
3.44B SEK
Turnover
5.35M SEK
Revenue
3.82M
EBIT %
-11,851.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21/8
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

Press release2026-07-07 08:00

Vicore Pharma deltar på Leerink Therapeutics Forum

Vicore Pharma Holding
Press release2026-07-07 08:00

Vicore Pharma to Participate in the Leerink Therapeutics Forum

Vicore Pharma Holding
Press release2026-07-06 08:00

Vicore Pharma utser Rob Slack till Chief Scientific Officer

Vicore Pharma Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-07-06 08:00

Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

Vicore Pharma Holding
Press release2026-07-01 22:01

Vicore Pharma inleder handel på The Nasdaq Stock Market i USA

Vicore Pharma Holding
Press release2026-07-01 22:01

Vicore Pharma to Commence Trading in the United States on The Nasdaq Stock Market

Vicore Pharma Holding
Press release2026-06-02 08:00

Vicore Pharma arrangerar webcast om buloxibutid och det framväxande landskapet för IPF-behandlingar

Vicore Pharma Holding
Press release2026-06-02 08:00

Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape

Vicore Pharma Holding
Press release2026-05-26 08:00

Vicore Pharma presenterar på Jefferies Global Healthcare Conference

Vicore Pharma Holding
Press release2026-05-26 08:00

Vicore Pharma to Present at the Jefferies Global Healthcare Conference

Vicore Pharma Holding
Press release2026-05-22 14:38

Vicore Pharma går vidare med amerikansk sekundärnotering och lämnar in registreringshandling till SEC

Vicore Pharma Holding
Press release2026-05-22 14:38

Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

Vicore Pharma Holding
Regulatory press release2026-05-11 09:07

Finansinspektionen: Flaggningsmeddelande i Vicore Pharma Holding AB

Vicore Pharma Holding
Press release2026-05-07 13:51

Investor Studios: Vicore Pharmas VD & CMO intervjuas om IPF, buloxibutid & ASPIRE-studien

Vicore Pharma Holding
Press release2026-05-07 08:00

Vicore Pharma utser Peter Guenter till styrelseledamot

Vicore Pharma Holding
Press release2026-05-07 08:00

Vicore Pharma Elects Peter Guenter to its Board of Directors

Vicore Pharma Holding
Regulatory press release2026-05-06 16:30

Kommuniké från årsstämma i Vicore Pharma Holding AB (publ)

Vicore Pharma Holding
Regulatory press release2026-05-06 16:30

Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)

Vicore Pharma Holding
Regulatory press release2026-05-06 08:00

Delårsrapport januari – mars 2026

Vicore Pharma Holding
Regulatory press release2026-05-06 08:00

Interim Report January – March 2026

Vicore Pharma Holding